E. coli infection induces caspase dependent degradation of NF-κB and reduces the inflammatory response in macrophages (original) (raw)

Abstract

Objective and Background: Macrophages are known to be one of the initial responders to bacterial infection. While infection of macrophages with bacteria induces apoptosis, a pro-inflammatory response is also elicited. Thus, the aim of this study is to further elucidate the differential effect of infections with bacteria on the survival and function of macrophages. Methods and results: THP-1 monocytic cells induced to differentiate into macrophages were infected with non-pathogenic Escherichia coli (E. coli) and analyzed for apoptosis and inflammatory response over time. Following infection with E. coli macrophages underwent apoptosis which was reduced by the general caspase inhibitor, zVAD.fmk. Inhibition of caspase activity resulted in increased DNA binding activity of NF-κB and enhanced production of NF-κB-dependent reporter gene expression following infection. Increased activity of NF-κB was independent of IκBα since IκBα degradation was unaffected by zVAD.fmk. Further, suppression of caspase activity reduced the proteolytic cleavage of NF-κB. The increased activity of NF-κB in the zVAD.fmk-treated macrophages was associated with a markedly enhanced production of pro-inflammatory cytokines and elimination of E. coli. Conclusion: These data indicate that infection of macrophages with E. coli induces a caspase-dependent inhibition of NF-κB that results in a reduced production of pro-inflammatory cytokines and impaired clearance of bacteria.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (60)

  1. Baeuerle PA, Baltimore D. I kappa B: a specifi c inhibitor of the NF-kappa B transcription factor. Science 1988; 242: 540-6.
  2. Urban MB, Schreck R, Baeuerle PA. NF-kappa B contacts DNA by a heterodimer of the p50 and p65 subunit. Embo J 1991; 10: 1817-25.
  3. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 1997; 388: 548-54.
  4. Ghosh S, Baltimore D. Activation in vitro of NF-kappa B by phos- phorylation of its inhibitor I kappa B. Nature 1990; 344: 678-82.
  5. Elewaut D, DiDonato JA, Kim JM, Truong F, Eckmann L, Kagnoff MF. NF-kappa B is a central regulator of the intestinal epithelial cell innate immune response induced by infection with enteroinva- sive bacteria. J Immunol 1999; 163: 1457-66.
  6. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evo- lutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16: 225-60.
  7. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA compo- nent of NF-kappa B. Nature 1995; 376: 167.
  8. Rosenfeld ME, Prichard L, Shiojiri N, Fausto N. Prevention of hepatic apoptosis and embryonic lethality in RelA/TNFR-1 double knockout mice. Am J Pathol 2000; 156: 997-1007.
  9. Alcamo E, Mizgerd JP, Horwitz BH, Bronson R, Beg AA, Scott M, et al. Targeted mutation of TNF receptor I rescues the RelA-defi - cient mouse and reveals a critical role for NF-kappa B in leukocyte recruitment. J Immunol 2001; 167: 1592-600.
  10. Mills SD, Boland A, Sory MP, van der Smissen P, Kerbourch C, Finlay BB, et al. Yersinia enterocolitica induces apoptosis in macrophages by a process requiring functional type III secretion and translocation mechanisms and involving YopP, presumably acting as an effector protein. Proc Natl Acad Sci U S A 1997; 94: 12638-43.
  11. Monack DM, Mecsas J, Ghori N, Falkow S. Yersinia signals mac- rophages to undergo apoptosis and YopJ is necessary for this cell death. Proc Natl Acad Sci U S A 1997; 94: 10385-90.
  12. Monack DM, Mecsas J, Bouley D, Falkow S. Yersinia-induced ap- optosis in vivo aids in the establishment of a systemic infection of mice. J Exp Med 1998; 188: 2127-37.
  13. Zychlinsky A, Prevost MC, Sansonetti PJ. Shigella fl exneri induces apoptosis in infected macrophages. Nature 1992; 358: 167-9.
  14. Zychlinsky A, Kenny B, Prevost MC, Holland IB, Sansonetti PJ. The ipaB gene of Shigella fl exneri and macrophage-programmed cell death. Infect Agents Dis 1993; 2: 212-4.
  15. Haase R, Kirschning CJ, Sing A, Schrottner P, Fukase K, Kusumo- to S, et al. A dominant role of Toll-like receptor 4 in the signaling of apoptosis in bacteria-faced macrophages. J Immunol 2003; 171: 4294-303.
  16. Zhang Y, Bliska JB. Role of Toll-like receptor signaling in the apoptotic response of macrophages to Yersinia infection. Infect Immun 2003; 71: 1513-9.
  17. Ruckdeschel K, Harb S, Roggenkamp A, Hornef M, Zumbihl R, Kohler S, et al. Yersinia enterocolitica impairs activation of transcription factor NF-kappaB: involvement in the induction of programmed cell death and in the suppression of the macrophage tumor necrosis factor alpha production. J Exp Med 1998; 187: 1069-79.
  18. Kitamura M. NF-kappaB-mediated self defense of macrophages faced with bacteria. Eur J Immunol 1999; 29: 1647-55.
  19. Simovart HE, Poldoja E, Kokk K, Tapfer H, Liigant A, Talvik R, et al. Changes of activated macrophages and apoptotic cell count in the organs of rats during experimental sepsis. Medicina (Kaunas) 2003; 39: 932-9.
  20. Tapfer H, Liigant A, Simovart HE, Poldoja E, Kokk K, Naaber P, et al. Dissemination of bacteria in multiple organs associated with ap- optosis and macrophage activity in different stages of experimental sepsis. Scand J Surg 2003; 92: 163-70.
  21. Iwata A, Stevenson VM, Minard A, Tasch M, Tupper J, Lagasse E, et al. Over-expression of Bcl-2 provides protection in septic mice by a trans effect. J Immunol 2003; 171: 3136-41.
  22. Hotchkiss RS, Chang KC, Swanson PE, Tinsley KW, Hui JJ, Klender P, et al. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat Immunol 2000; 1: 496-501.
  23. Hotchkiss RS, Tinsley KW, Swanson PE, Chang KC, Cobb JP, Buchman TG, et al. Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc Natl Acad Sci U S A 1999; 96: 14541-6.
  24. Lorber B, Swenson RM. The bacteriology of intra-abdominal in- fections. Surg Clin North Am 1975; 55: 1349-54.
  25. Swenson RM, Lorber B, Michaelson TC, Spaulding EH. The bacteriology of intra-abdominal infections. Arch Surg 1974; 109: 398-9.
  26. Hau T. Bacteria, toxins, and the peritoneum. World J Surg 1990; 14: 167-75.
  27. Smith RC, Branellec D, Gorski DH, Guo K, Perlman H, Dedieu J-F, et al. p21 CIP1 -mediated inhibition of cell proliferation by over- expression of the gax homeodomain gene. Genes Dev 1997; 11: 1674-1689.
  28. Kishore N, Sommers C, Mathialagan S, Guzova J, Yao M, Hauser S, et al. A selective IKK-2 inhibitor blocks NF-kappa B-dependent gene expression in interleukin-1 beta-stimulated synovial fi brob- lasts. J Biol Chem 2003; 278: 32861-71.
  29. Graham FL, van der Eb AJ. A new technique for assay of infectivity of human adenovirus 5 DNA. Virology 1973; 52: 456-463.
  30. Hacker H, Furmann C, Wagner H, Hacker G. Caspase-9/-3 activa- tion and apoptosis are induced in mouse macrophages upon inges- tion and digestion of Escherichia coli bacteria. J Immunol 2002; 169: 3172-9.
  31. Kirschnek S, Ying S, Fischer SF, Hacker H, Villunger A, Hochrein H, et al. Phagocytosis-induced apoptosis in macrophages is medi- Vol. 55, 2006
  32. E. coli induced apoptosis of macrophages reduces the infl ammatory response 9 ated by up-regulation and activation of the Bcl-2 homology domain 3-only protein Bim. J Immunol 2005; 174: 671-9.
  33. Stravodimos KG, Singhal PC, Sharma S, Reddy K, Smith AD. Es- cherichia coli promotes macrophage apoptosis. J Endourol 1999; 13: 273-7.
  34. Baran J, Guzik K, Hryniewicz W, Ernst M, Flad HD, Pryjma J. Apoptosis of monocytes and prolonged survival of granulocytes as a result of phagocytosis of bacteria. Infect Immun 1996; 64: 4242-8.
  35. Mehta K, Lopez-Berestein G. Expression of tissue transglutami- nase in cultured monocytic leukemia (THP-1) cells during differ- entiation. Cancer Res 1986; 46: 1388-94.
  36. Pantazis P, Bonner WM. Specifi c alterations in the pattern of histone-3 synthesis during conversion of human leukemic cells to terminally differentiated cells in culture. Differentiation 1984; 28: 186-90.
  37. Auwerx J. The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation. Ex- perientia 1991; 47: 22-31.
  38. Takashiba S, Van Dyke TE, Amar S, Murayama Y, Soskolne AW, Shapira L. Differentiation of monocytes to macrophages primes cells for lipopolysaccharide stimulation via accumulation of cyto- plasmic nuclear factor kappaB. Infect Immun 1999; 67: 5573-8.
  39. Alessio M, De Monte L, Scirea A, Gruarin P, Tandon NN, Sitia R. Synthesis, processing, and intracellular transport of CD36 during monocytic differentiation. J Biol Chem 1996; 271: 1770-5.
  40. Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev 2004; 18: 2195-224.
  41. Renard P, Ernest I, Houbion A, Art M, Le Calvez H, Raes M, et al. Development of a sensitive multi-well colorimetric assay for active NFkappaB. Nucleic Acids Res 2001; 29: E21.
  42. Levkau B, Scatena M, Giachelli CM, Ross R, Raines EW. Apop- tosis overrides survival signals through a caspase-mediated domi- nant-negative NF-kappa B loop. Nat Cell Biol 1999; 1: 227-33.
  43. Hersh D, Monack DM, Smith MR, Ghori N, Falkow S, Zychlinsky A. The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1. Proc Natl Acad Sci U S A 1999; 96: 2396- 401.
  44. Dalrymple SA, Slattery R, Aud DM, Krishna M, Lucian LA, Mur- ray R. Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection. Infect Immun 1996; 64: 3231-5.
  45. Wellmer A, Gerber J, Ragheb J, Zysk G, Kunst T, Smirnov A, et al. Effect of defi ciency of tumor necrosis factor alpha or both of its receptors on Streptococcus pneumoniae central nervous system infection and peritonitis. Infect Immun 2001; 69: 6881-6.
  46. Huber AR, Kunkel SL, Todd RF, 3rd, Weiss SJ. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 1991; 254: 99-102.
  47. Albrecht H, Schook LB, Jongeneel CV. Nuclear migration of NF-kappa B correlates with TNF-alpha mRNA accumulation. J Infl amm 1995; 45: 64-71.
  48. Mastronarde JG, He B, Monick MM, Mukaida N, Matsushima K, Hunninghake GW. Induction of interleukin (IL)-8 gene expression by respiratory syncytial virus involves activation of nuclear factor (NF)-kappa B and NF-IL-6. J Infect Dis 1996; 174: 262-7.
  49. Dockrell DH, Marriott HM, Prince LR, Ridger VC, Ince PG, Hellewell PG, et al. Alveolar macrophage apoptosis contributes to pneumococcal clearance in a resolving model of pulmonary infec- tion. J Immunol 2003; 171: 5380-8.
  50. Dockrell DH, Lee M, Lynch DH, Read RC. Immune-mediated phagocytosis and killing of Streptococcus pneumoniae are associ- ated with direct and bystander macrophage apoptosis. J Infect Dis 2001; 184: 713-22.
  51. Mecsas JJ, Strauss EJ. Molecular mechanisms of bacterial viru- lence: type III secretion and pathogenicity islands. Emerg Infect Dis 1996; 2: 270-88.
  52. Keane J, Remold HG, Kornfeld H. Virulent Mycobacterium tuber- culosis strains evade apoptosis of infected alveolar macrophages. J Immunol 2000; 164: 2016-20.
  53. Spira A, Carroll JD, Liu G, Aziz Z, Shah V, Kornfeld H, et al. Apop- tosis genes in human alveolar macrophages infected with virulent or attenuated Mycobacterium tuberculosis: a pivotal role for tumor necrosis factor. Am J Respir Cell Mol Biol 2003; 29: 545-51.
  54. Liu H, Ma Y, Pagliari LJ, Perlman H, Yu C, Lin A, et al. TNF-al- pha-induced apoptosis of macrophages following inhibition of NF- kappa B: a central role for disruption of mitochondria. J Immunol 2004; 172: 1907-15.
  55. Pagliari LJ, Perlman H, Liu H, Pope RM. Macrophages require constitutive NF-kappaB activation to maintain A1 expression and mitochondrial homeostasis. Mol Cell Biol 2000; 20: 8855-65.
  56. Palmer LE, Hobbie S, Galan JE, Bliska JB. YopJ of Yersinia pseu- dotuberculosis is required for the inhibition of macrophage TNF- alpha production and downregulation of the MAP kinases p38 and JNK. Mol Microbiol 1998; 27: 953-65.
  57. Schesser K, Spiik AK, Dukuzumuremyi JM, Neurath MF, Petters- son S, Wolf-Watz H. The yopJ locus is required for Yersinia-medi- ated inhibition of NF-kappaB activation and cytokine expression: YopJ contains a eukaryotic SH2-like domain that is essential for its repressive activity. Mol Microbiol 1998; 28: 1067-79.
  58. Ruckdeschel K, Richter K, Mannel O, Heesemann J. Arginine-143 of Yersinia enterocolitica YopP crucially determines isotype-related NF-kappaB suppression and apoptosis induction in macrophages. Infect Immun 2001; 69: 7652-62.
  59. Ruckdeschel K, Mannel O, Richter K, Jacobi CA, Trulzsch K, Rouot B, et al. Yersinia outer protein P of Yersinia enterocolitica simultaneously blocks the nuclear factor-kappa B pathway and exploits lipopolysaccharide signaling to trigger apoptosis in mac- rophages. J Immunol 2001; 166: 1823-31.
  60. Ravi R, Bedi A, Fuchs EJ, Bedi A. CD95 (Fas)-induced caspase- mediated proteolysis of NF-kB. Cancer Res. 1998; 58: 882-886.